Skip to main content

Animations

MJFF Publications

5111 - 5120 of 8819 Results
Title
Year
  • Year
  • 2017
  • 2012
  • 2018
  • 2024
  • 2015
  • 2016
  • 2012
  • 2006
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0482-0
    Citation Count: 114
  • Summary Details
    RESTRICTED
    Title: Singing in groups for Parkinson's disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disorders
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.02.009
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20‐dependent negative feedback loop
    Journal Name: Glia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/glia.23337
    Citation Count: 133
  • Summary Details
    OPEN
    Title: Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.4c00493
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2015.11.018
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
    Journal Name: CNS Neuroscience & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cns.12660
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug class
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25082
    Citation Count: 48
  • Summary Details
    RESTRICTED
    Title: Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2006.08.029
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nly056
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007
    Citation Count: 126
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.